Literature DB >> 2575573

Involvement of adrenergic mechanism in hyperglycemia due to SCN stimulation.

T Fujii1, S Inoue, K Nagai, H Nakagawa.   

Abstract

Previously we found that in rats, electrical stimulation of the suprachiasmatic nucleus (SCN) of the hypothalamus elicited hyperglycemia associated with hyperglucagonemia without immediate hyperinsulinemia. To clarify the mechanism of these responses, we examined the effects of blockers of the autonomic nervous system on these responses. Hexamethonium, a ganglion blocker, suppressed the hyperglycemic and hyperglucagonemic responses to electrical stimulation of the SCN. Both bunazosin, an alpha 1-adrenergic blocker, and yohimbin, an alpha 2-adrenergic blocker, increased the level of insulin before stimulation, but only the latter suppressed the hyperglycemic and hyperglucagonemic responses. Propranolol, a beta-adrenergic blocker, partially inhibited the responses. These findings suggest that alpha 2- and beta-adrenergic mechanisms are involved in the hyperglycemic and hyperglucagonemic responses to SCN stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575573     DOI: 10.1055/s-2007-1009309

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

Review 1.  Coordinated regulation of circadian rhythms and homeostasis by the suprachiasmatic nucleus.

Authors:  Hachiro Nakagawa; Nobuaki Okumura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 2.  Circadian control of glucose metabolism.

Authors:  Andries Kalsbeek; Susanne la Fleur; Eric Fliers
Journal:  Mol Metab       Date:  2014-03-19       Impact factor: 7.422

Review 3.  Circadian rhythms and metabolism: from the brain to the gut and back again.

Authors:  Matthew R Cribbet; Ryan W Logan; Mathew D Edwards; Erin Hanlon; Clara Bien Peek; Jeremy J Stubblefield; Sridhar Vasudevan; Fiona Ritchey; Ellen Frank
Journal:  Ann N Y Acad Sci       Date:  2016-09-02       Impact factor: 6.499

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.